Clarisa Blattner: What Labs Can Learn from Reimbursement Variability Across Health Plans
An argument is made for clinical laboratories to use payer rate transparency as a cornerstone of commercial intelligence
News
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Subscribe today for access to
Articles and Reports
Beyond Prior Authorization Reform: The Next Measure of Administrative Simplification
Clinical labs can serve as early observers of this transition
Clarisa Blattner: MACs Refresh Medicare DOS Guidance
Why clinical laboratories should pay attention even though date-of-service rules haven’t changed
SCOTUS Ruling May Save Labs from Baseless Qui Tam Lawsuits
The recent 8-1 decision expands the DOJ’s power to request such cases be thrown out.
Insights into Attracting Top Talent to Your Lab
Lab staffing expert shares three key strategies for recruiting and retaining talent during difficult economic times.
Could SALSA Pass This Year?
Lab industry insiders say they’re confident the Saving Access to Laboratory Services Act (SALSA) will pass in 2023.
Weekly Enforcement Report: Big Settlements but Lab Cases Scarce
While the last few weeks haven’t seen many lab-related enforcement actions, several healthcare companies had to pay big.
Supporting Medical Labs During Tough Economic Times
G2 Intelligence’s June 13-14 virtual event offers expert advice to help labs navigate today’s economic challenges.
How Super-Clean Orders Could Disrupt Health Care
Two recent panel discussions focused on why super-clean orders are important in health care and the challenges that currently prevent them.
Weekly Enforcement Report: Drug Testing Fraud Dominates
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
Proposed Rule Would Water Down CLIA Requirements for Lab Directors and Testing Personnel
While the rule has not yet been approved, if it is, nursing degrees would be considered the equivalent of biological science degrees.
Quest Expands into MRD Liquid Biopsy with Haystack Oncology Buy
The acquisition of the Johns Hopkins spin out and its liquid biopsy ctDNA test will significantly strengthen Quest’s oncology offerings.
Convicted Lab Owner Fails to Report to Prison
In addition to the usual FCA-related fare, an arrest warrant was issued for a convicted lab co-owner after he failed to show up for prison.
